Evidence map›Paper›PMID 38680958›Full record

ArticleJACC. Basic to translational science2024

Carotid Baroreceptor Stimulation Improves Pulmonary Arterial Remodeling and Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.

Jing Wang, Jie Chen, Ling Shu, Ruoliu Zhang, Mingyan Dai, Xuesheng Fang, Zhiling Hu, Lingling Xiao, Zhaoqing Xi, Junxia Zhang and 1 more

Abstract read
In one paragraph

Article in JACC. Basic to translational science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. The coming era of neuromodulation therapies: expectations for baroreceptor stimulation.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jing WangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Jie ChenDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Ling ShuDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Ruoliu ZhangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Mingyan DaiDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Xuesheng FangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Zhiling HuDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Lingling XiaoDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Zhaoqing XiDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Junxia ZhangDepartment of Endocrinology, Taikang Tongji (Wuhan) Hospital, Wuhan, China.
Mingwei BaoDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autonomic nervous system imbalance is intricately associated with the severity and prognosis of pulmonary arterial hypertension (PAH). Carotid baroreceptor stimulation (CBS) is a nonpharmaceutical intervention for autonomic neuromodulation. The effects of CBS on monocrotaline-induced PAH were investigated in this study, and its underlying mechanisms were elucidated. The results indicated that CBS improved pulmonary hemodynamic status and alleviated right ventricular dysfunction, improving pulmonary arterial remodeling and right ventricular remodeling, thus enhancing the survival rate of monocrotaline-induced PAH rats. The beneficial effects of CBS treatment on PAH might be mediated through the inhibition of sympathetic overactivation and inflammatory immune signaling pathways.

Indexed as

carotid baroreceptor stimulationpulmonary arterial hypertensionpulmonary arterial remodelingright ventricular dysfunctionsympathetic nervous system

Identifiers

PMID38680958
PMCPMC11055206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.